Stock Scorecard



Stock Summary for Exelixis Inc (EXEL) - $42.52 as of 6/10/2025 9:03:32 PM EST

Total Score

16 out of 30

Safety Score

60 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for EXEL

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for EXEL

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for EXEL

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for EXEL

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for EXEL (60 out of 100)

Stock Price Rating (Max of 10) 8
Historical Stock Price Rating (Max of 10) 6
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 6
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 8
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for EXEL

3 Reasons Why Growth Investors Shouldn't Overlook Exelixis ( EXEL ) 6/9/2025 4:45:00 PM
Are You Looking for a Top Momentum Pick? Why Exelixis ( EXEL ) is a Great Choice 6/6/2025 4:00:00 PM
2 Soaring Stocks Wth More Upside Potential 6/5/2025 7:19:00 AM
Exelixis Stock Surges 28% YTD: Should You Buy Now or Sell? 6/4/2025 2:18:00 PM
Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks 6/4/2025 10:57:00 AM
Top 4 Value Stocks With Impressive PEG Ratios to Buy Now 5/30/2025 1:35:00 PM
2 Top Stocks to Buy With Less Than $100 5/30/2025 12:00:00 PM
3 Reasons Why Growth Investors Shouldn't Overlook Exelixis ( EXEL ) 5/23/2025 4:45:00 PM
Earnings Estimates Moving Higher for Exelixis ( EXEL ) : Time to Buy? 5/23/2025 4:20:00 PM
Exelixis ( EXEL ) Upgraded to Buy: What Does It Mean for the Stock? 5/23/2025 4:00:00 PM

Financial Details for EXEL

Company Overview

Ticker EXEL
Company Name Exelixis Inc
Country USA
Description Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California.
Sector Name TRADE & SERVICES
Industry Name SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Most Recent Quarter 3/31/2025
Next Earnings Date 8/12/2025

Stock Price History

Last Day Price 42.52
Price 4 Years Ago 18.28
Last Day Price Updated 6/10/2025 9:03:32 PM EST
Last Day Volume 1,783,226
Average Daily Volume 3,425,062
52-Week High 48.85
52-Week Low 21.36
Last Price to 52 Week Low 99.06%

Valuation Measures

Trailing PE 19.60
Industry PE 62.92
Sector PE 50.71
5-Year Average PE 32.60
Free Cash Flow Ratio 63.46
Industry Free Cash Flow Ratio 38.69
Sector Free Cash Flow Ratio 61.61
Current Ratio Most Recent Quarter 3.50
Total Cash Per Share 0.67
Book Value Per Share Most Recent Quarter 7.75
Price to Book Ratio 5.51
Industry Price to Book Ratio 5.83
Sector Price to Book Ratio 11.01
Price to Sales Ratio Twelve Trailing Months 5.10
Industry Price to Sales Ratio Twelve Trailing Months 2.51
Sector Price to Sales Ratio Twelve Trailing Months 2.43
Analyst Buy Ratings 7
Analyst Strong Buy Ratings 4

Share Statistics

Total Shares Outstanding 272,708,000
Market Capitalization 11,595,544,160
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 2.47%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 358.30%
Annual Earnings Growth 150.89%
Reported EPS 12 Trailing Months 2.19
Reported EPS Past Year 0.62
Reported EPS Prior Year 1.92
Net Income Twelve Trailing Months 643,566,000
Net Income Past Year 521,267,000
Net Income Prior Year 207,765,000
Quarterly Revenue Growth YOY 30.60%
5-Year Revenue Growth 17.51%
Operating Margin Twelve Trailing Months 33.60%

Balance Sheet

Total Cash Most Recent Quarter 183,752,000
Total Cash Past Year 217,374,000
Total Cash Prior Year 262,994,000
Net Cash Position Most Recent Quarter 183,752,000
Net Cash Position Past Year 217,374,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 2,244,203,000
Total Stockholder Equity Prior Year 2,263,912,000
Total Stockholder Equity Most Recent Quarter 2,131,024,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 790,390,000
Free Cash Flow Per Share Twelve Trailing Months 2.90
Free Cash Flow Past Year 633,786,000
Free Cash Flow Prior Year 170,355,000

Options

Put/Call Ratio 0.04
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 1.05
MACD Signal 1.32
20-Day Bollinger Lower Band 31.22
20-Day Bollinger Middle Band 38.11
20-Day Bollinger Upper Band 44.99
Beta 0.28
RSI 59.11
50-Day SMA 32.58
150-Day SMA 24.08
200-Day SMA 23.02

System

Modified 6/9/2025 11:36:08 PM EST